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Abstract
Objectives—The PEACE study is a multi-
centre panel study of the acute eVects of
particles with a 50% cut oV aerodynamic
diameter of 10 µm (PM10), black smoke
(BS), sulphur dioxide (SO2), and nitrogen
dioxide (NO2) on respiratory health of
children with chronic respiratory symp-
toms. In the complete panels no consistent
association between air pollution and res-
piratory health was found. The study
evaluated whether potentially more sensi-
tive subgroups in the panels did show
eVects of air pollution.
Methods—To evaluate heterogeneity in
response to air pollution, eVect estimates
of air pollution on peak expiratory flow
(PEF) and respiratory symptoms were
calculated in subgroups based on presence
of chronic respiratory symptoms, use of
respiratory medication, atopy, sex, and
baseline lung function.
Results—The association between PEF
and air pollution was positive in asthmatic
children who used respiratory medication
whereas the associations tended to be
negative in children who did not use respi-
ratory medication selected only on cough.
No consistent association was found
among asthmatic children who did not use
medication. The association between daily
prevalence of symptoms and concentra-
tions of air pollution was not diVerent
between these subgroups.
Conclusion—None of the predefined po-
tentially more sensitive subgroups showed
a consistent association between air pollu-
tion, PEF, and respiratory symptoms.
(Occup Environ Med 1999;56:86–92)
Keywords: epidemiology; air pollution; children
There are indications that some groups of chil-
dren are more sensitive to air pollution than
others and that use of medication modifies the
relation between respiratory health and air pol-
lution. Pope et al1 reported associations be-
tween indicators of respiratory health (except
use of medication) and particles with a 50%
cut oV aerodynamic diameter of 10 µm (PM10)
to be stronger in school children selected on
respiratory symptoms by a screening question-
naire than in subjects selected on the basis of
diagnosed asthma. It was hypothesised that this
diVerence was caused by management of respi-
ratory health by use of medication, because in
the patient based sample the subjects usually
used asthma medication whereas in the school
based sample the subjects rarely did. In another
panel study by Pope and Dockery2 a sample
selected on the basis of asthmatic symptoms
but no use of medication reacted more strongly
than an asymptomatic sample. Peters et al
showed that use of medication attenuated the
associations between sulphate concentrations
and respiratory health.3 Besides the use of
medication other factors are related to the
response of a child to air pollution. In a study
by Roemer et al4 children selected on asthmatic
attacks in the previous year had a stronger
association between increases in PM10 or
sulphur dioxide (SO2) and decreased peak
expiratory flow (PEF) than children selected
on chronic cough. Timonen and Pekkanen
reported diVerences in association between
PEF, respiratory symptoms, and PM10, black
smoke (BS), SO2, and nitrogen dioxide (NO2)
in subgroups of children selected on cough or
on asthmatic symptoms in the Finnish PEACE
panel.5 Pershagen et al showed a relation
between wheezing bronchitis and chronic
exposure to outdoor concentrations of NO2 in
girls but not in boys.6 Brunekreef et al7 reported
that the association between lung function and
chronic exposure to air pollution assessed as
lorry traYc density was stronger in girls than in
boys. Atopy and lung function were related to
variability of PEF8 and the prevalence of acute
respiratory symptoms,9 so it might be that chil-
dren with an atopic constitution or a lower lung
function react diVerently to air pollution com-
pared with non-atopic children or children
with a better lung function. To our knowledge,
in epidemiological panel studies objective data
to characterise subjects (such as skin prick
tests) have not been evaluated with respect to
the response to air pollution.
The pollution eVects on asthmatic children
in Europe (PEACE) study was designed to
study the relation between short term changes
in air pollution and lung function, respiratory
symptoms, and use of medication. It is a
collection of panel studies that were conducted
in the winter of 1993–94 in 14 diVerent centres
in Europe. In that paper the PEACE data were
stratified to investigate if subgroups within the
panels, based on predefined characteristics,
reacted diVerently to short term changes in air
pollution. In the complete panels no consistent
association between air pollution and respira-
tory health was found.10 In this paper we evalu-
ate whether potentially more sensitive sub-
groups (using predefined characteristics) in the
panels did show eVects of air pollution.
Specifically we hypothesised that children
selected on asthma symptoms but not using
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medication; children with atopy; children with
low baseline lung function; and girls reacted
more strongly to air pollution than did the
complete panel.
Materials and methods
PEACE STUDY
The PEACE study is a collaboration of 14
European centres (appendix). All centres used
the same protocol for data collection and data
analysis. Design, methods, and results of the
individual panels11 as well as combined eVect
estimates for the complete panels have been
reported elsewhere.10 Each centre selected two
panels, one panel in an urban area and one in a
suburban or rural area (called here suburban
panel). The suburban panel was selected from
a community which had no major traYc emis-
sions, had no large industrial sources, had suf-
ficient size to select enough subjects and was
close to a site of an existing air pollution
measurement network. Suburban panels were
included to evaluate diVerences in eVects of air
pollution caused by level and composition of
air pollution, in panels paired by meteorologi-
cal characteristics. The subject selection and
characterisation were somewhat diVerent in
Hettstedt. Therefore, in this paper the data
from Hettstedt are excluded.
Children aged between 6 and12 years with
chronic respiratory symptoms were selected by
a screening questionnaire completed by par-
ents. The criteria for selection were: reporting
recent wheeze (apart from colds), recent
attacks of shortness of breath with wheezing,
recent dry cough (apart from colds), or asthma
ever diagnosed by a doctor. To further charac-
terise the children, atopy was assessed by skin
prick test, and pulmonary function was as-
sessed by forced expiratory manoeuvres. Skin
prick tests were carried out with the ALK sys-
tem (ALK laboratories, Horsholm, Denmark).
A common set of four single allergens was used
for all areas which covered the most important
allergens in the participating countries. These
allergens were house dust mite (Dermatopha-
goides pteronyssinus), cat fur, and pollen of
timothy grass (Phleum pratense) and birch
(Betula verrucosa). A positive control (hista-
mine) and a negative control (diluent) were
applied in each test. Two locally important
allergens were added by each individual
centre.11 A child was considered atopic if there
was a wheal reaction of >2 mm on one of the
tested allergens together with a negative
control <1 mm and a positive control of >0
mm. Forced expiratory manoeuvres were
performed with the protocol of the European
Community for Coal and Steel (ECCS).12 13
The equipment used in the centres was not
identical but had to fulfil the technical require-
ments of the ECCS. Selection of values was
according to the ECCS.12 13 The measured
values were expressed as a percentage of the
predicted values calculated from the reference
equations given in Quanjer et al.14
Peak expiratory flow (PEF) was measured
each day in the morning and in the evening for
at least 2 months. All centres used the mini
Wright peak flowmeter. A parent completed a
daily diary for the child recording the presence
and severity of respiratory symptoms and use
of medication for respiratory symptoms.
Concurrent air pollution measurements
were performed in both the urban and
suburban locations. Daily 24 hour measure-
ments of PM10, BS, SO2, and NO2 were made at
sites not influenced by nearby sources, so were
called background sites. More information
about the measurement methods is given
elsewhere.11 15
STATISTICAL METHODS
Our analytical approach consisted of the calcu-
lation of the association between air pollution
and respiratory health in the subgroups already
defined within the individual panels. Next, the
regression slopes calculated for the individual
panels were combined to obtain an average
slope in the subgroups—such as children with
and without atopy. To avoid large changes in
day to day composition of the reporting group,
children were included in the analysis if they
had valid PEF measurements and respiratory
symptoms on >60% of the days. Also, only
children with no missing information on sex,
skin prick testing, lung function testing, and
with a positive response to one of the screening
questions were included to avoid diVerences in
the total number of children in the diVerent
subgroup analyses. Subgroups were defined on
the basis of use of medication, selection
question, sex, atopy, and lung function. Atopy
subgroups were based on the skin prick test
results. Lung function subgroups were made by
dividing the values expressed as percentage of
predicted maximal mid expiratory flow
(MMEF) or forced expiratory volume in 1 sec-
ond (FEV1) into quartiles. To avoid subjects
with diVerent lung function levels being
categorised in the same group, quartiles were
calculated over the whole group, independently
of centre. To increase the contrast, the children
with the worst lung function were compared
with the children with a normal lung function.
More specifically, a comparison was made
between the subjects in the lowest quartile v
the subjects above the median. Three sub-
groups based on use of medication and
selection questionnaire were made: selected on
asthmatic symptoms (wheeze or asthma diag-
nosis) and use of respiratory medication
(AST+), and no respiratory medication
(AST−), and a third group selected only on the
question on nightly coughing but no medi-
cation (cough−). Medication was defined as the
use of bronchodilators—such as salbutamol,
albuterol, fenoterol, terbutaline—or mainte-
nance or preventive medication—such as
cromolyn, theophylline, antihistamine, or
corticosteroid—on any day during the study
period. There were few subjects selected only
on the question on nightly coughing and use of
medication (n=23), so these were left out in
this subgroup analysis.
The association between PEF and concentra-
tions of air pollutants was calculated by linear
regression for each child separately. This analy-
sis included correction for first order autocorre-
lation in the residuals. In the subgroups the dis-
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tribution of these individual coefficients was
studied next. To correct for subject characteris-
tics, weighted multiple linear regression was
performed with the individual coeYcients as
the dependent variables and subgroup indica-
tors as independent variables, with the weights
being the inverse of the variance of the
individual coeYcients. Cook’s distance was cal-
culated to evaluate the influence of each obser-
vation.16 Observations with extreme values
(>1.0) for Cook’s distance were deleted to test
the stability of the calculated slopes.
The symptoms in the diaries were recoded
to 0 (no symptom) and 1 (slight, moderate or
severe symptom) and daily prevalence was cal-
culated within subgroups. All panels were
analysed separately. Daily prevalence within a
subgroup was defined as the fraction of
children for whom the presence of a respira-
tory symptom or use of medication was
reported from those children who provided
valid diary data for that symptom on that day
within that subgroup. The association between
subgroup specific symptom prevalence and air
pollution was evaluated with logistic
regression but under the assumption of
normally distributed residuals. This was done
because when analysing prevalence with bino-
mial distributed residuals the residuals showed
substantial underdispersion. The observations
were weighted by the number of reporting
children within a subgroup on each day. Cor-
rection for autocorrelation of residuals was
made assuming a first order autoregressive
structure. The respiratory symptoms cough,
phlegm, combined upper respiratory symp-
toms (runny or stuVy nose or sore throat), and
lower respiratory symptoms (shortness of
breath, wheeze, asthma attacks) were ana-
lysed. The prevalence of use of bronchodila-
tors was also analysed.
The regression slopes of the components of
air pollution from the logistic regression mod-
els of the separate panels were used to calculate
a combined eVect estimate for each subgroup.
To avoid calculations being based on few sub-
jects or few reported symptoms which could
lead to extreme eVect estimates, data from a
subgroup of a specific panel were only included
if they consisted of more than five subjects and
had a mean prevalence >3%. A combined fixed
eVect estimate was calculated as the weighted
mean of the subgroup specific slopes with the
weights being the inverse of the variance of the
slope. The standard error (SE) of the com-
bined slope was calculated as the inverse of the
square root of the sum of the weights.
Heterogeneity of subgroup specific slopes was
evaluated by a ÷2 test for homogeneity.17 In the
case of homogeneity the combined slope
calculated as a fixed eVect was considered to be
an appropriate estimate. A conservative cut oV
point of a p value <0.25 was chosen to
determine heterogeneity. In the case of
heterogeneity (p<0.25) combined eVect esti-
mates with random eVect estimation were
calculated.17 The combined eVect estimate was
expressed as an odds ratio (OR) for a 100 µg/m3
increase in air pollution.
The explanatory variables for PEF as well as
symptom prevalence were 24 hour average
concentrations of PM10, BS, SO2, and NO2,
analysed separately because of the high correla-
tion (r>0.6) between pollutants. Current day
concentration (lag 0), previous day concentra-
tion (lag 1), concentration of 2 days before (lag
2), and the average of lag 0–6 days (7 day
mean) were analysed separately. Minimum
temperature, a dummy variable indicating nor-
mal school days versus holidays or weekends
and time trend were included as possible con-
founders in PEF as well as prevalence analysis.
Time trend was included in the prevalence
Table 1 Characteristics of subjects included by panel
Subjects n
Atopic*
n (%)
MMEF† quartile
n (%)
Cough-‡
n (%)
AST+‡
n (%)
AST- ‡
n (%)
Umeå (Sweden) Urban 72 40 (56) 27 (38) 11 (15) 25 (35) 36 (50)
Suburban 69 43 (62) 21 (30) 10 (15) 36 (52) 23 (33)
Malmö (Sweden) Urban 64 31 (48) 22 (34) 15 (23) 22 (34) 25 (39)
Suburban 69 38 (55) 21 (30) 21 (30) 19 (28) 28 (41)
Kuopio (Finland) Urban 85 53 (62) 24 (28) 45 (53) 11 (13) 28 (33)
Suburban 82 49 (60) 14 (17) 44 (54) 14 (17) 21 (26)
Oslo (Norway) Urban 40 19 (48) 11 (28) 6 (15) 8 (20) 26 (65)
Suburban 49 27 (55) 13 (27) 7 (14) 18 (37) 24 (49)
Amsterdam (The Netherlands) Urban 52 27 (52) 14 (27) 18 (35) 11 (21) 23 (44)
Suburban 61 23 (38) 18(30) 27 (44) 13 (21) 21 (34)
Berlin (Germany) Urban 46 28 (61) 23 (50) 2 (4) 14 (30) 30 (65)
Suburban 57 34 (60) 23 (40) 2 (4) 11 (19) 44 (77)
Katowice (Poland) Urban 68 33 (49) 22 (32) 24 (35) 3 (4) 40 (59)
Suburban 71 21 (30) 26 (37) 10 (14) 6 (9) 54 (76)
Cracow (Poland) Urban 42 3 (7) 9 (21) 21 (50) 2 (5) 19 (45)
Suburban 60 32 (53) 4 (7) 20 (33) 10 (17) 29 (48)
Teplice (Czech Republic) Urban 75 12 (16) 9 (12) 44 (59) 3 (4) 27 (36)
Suburban 75 20 (27) 5 (7) 25 (33) 15 (20) 34 (45)
Prague (Czech Republic) Urban 66 32 (49) 25 (38) 1 (2) 19 (29) 46 (70)
Suburban 68 55 (81) 24 (35) 4 (6) 29 (43) 30 (44)
Budapest (Hungary) Urban 67 27 (40) 9 (13) 29 (43) 10 (15) 28 (42)
Suburban 58 34 (59) 8 (14) 18 (31) 5 (9) 34 (59)
Pisa (Italy) Urban 44 35 (80) 11 (25) 0 (0) 16 (36) 28 (64)
Suburban 48 27 (56) 5 (10) 8 (17) 14 (29) 25 (52)
Athens (Greece) Urban 68 12 (18) 7 (10) 31 (46) 8 (12) 26 (38)
Suburban 65 15 (23) 8 (12) 14 (22) 17 (26) 29 (45)
Total 1621 770 (48) 405 (25) 457 (28) 359 (22) 778 (48)
*Children with one or more positive skin prick test reactions. †Children in lowest MMEF quartile. ‡Children selected on nightly coughing only, no medication used
during study period (Cough-); selected on asthma question, no medication use during study period (AST-); selected on asthma question, and did use medication dur-
ing study period (AST+).
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analysis as a linear, quadratic, and cubic term
to correct for long term time trends. In the PEF
analysis time trend was included as a square
root and a linear term to correct for a possible
training eVect and lung growth, respectively.
Results
The characteristics of the subjects included are
presented in table 1 by panel. The percentage
of atopic children within the panels ranges
from 7% in the urban location of Cracow to
81% in the suburban location of Prague. Also
the prevalence of positive responses on the
selection questions show a wide range. These
diVerences probably reflect the slight modifica-
tions in selection procedure which some
centres made during the fieldwork.
A wide range of concentrations of air pollu-
tion was included, from low concentrations of
both gaseous and particulate components in
Scandinavia, higher concentrations in western
Europe and the highest concentrations in cen-
tral and southern Europe. Mean concentra-
tions during the study period for PM10 ranged
from 11.2 µg/m3 (Oslo, suburban) to 98.8
µg/m3 (Athens, urban), for BS from 4.5 µg/m3
(Malmö, suburban) to 109.2 µg/m3 (Athens,
urban), for SO2 from 2.7 µg/m
3 (Umeå, urban)
to 113.9 µg/m3(Prague, urban), and for NO2
from 8.9 µg/m3 (Malmö, suburban) to 74.9
µg/m3 (Athens, urban). More information
about the concentrations of air pollutants is
published elsewhere.15
ASSOCIATION BETWEEN AIR POLLUTION AND PEF
Table 2 shows the median of regression coeY-
cients of air pollution representations on
evening PEF in the subgroups. There was no
consistent pattern of diVerences in reaction to
air pollution between the subgroups based on
sex, atopy, or lung function. Regression analy-
sis, including all subgroup indicators simulta-
neously, confirmed this pattern.
Table 2 also shows that the median coeY-
cients in the AST+ group were positive for all
components with significant median coeY-
cients for BS 7 day mean, SO2 lag 0, lag 1, 7day
mean, and NO2 lag 1. On the other hand, most
of the median coeYcients in the cough− group
were negative, with PM10 lag 1 reaching signifi-
cance. The median coeYcients of the AST−
group were generally positive but none of the
coeYcients diVered significantly from zero.
Restriction of the data to the centres with the
highest mean prevalence of use of bronchodila-
tors in the AST+ group (Berlin (Germany),
Prague (Czech Republic), Malmö and Umeå
(Sweden), Pisa (Italy), Athens (Greece), Am-
sterdam (the Netherlands)) showed that the
median coeYcients of the AST+ group became
more positive and increased in significance.
Median coeYcients of the AST+ group in the
other centres no longer diVered consistently
from zero.
The median coeYcients on morning PEF
showed the same pattern for the subgroups
based on the selection questionnaire and use of
medication but the eVect was less pronounced.
There was no clear pattern within any of the
other stratifications of the individual coeY-
cients on morning PEF (not presented).
ASSOCIATION BETWEEN AIR POLLUTION AND
PREVALENCE OF SYMPTOMS AND USE OF
MEDICATION
The eVect estimates of air pollution on
prevalence of upper respiratory symptoms,
lower respiratory symptoms, and use of medi-
cation of the subgroups based on atopy are in
table 3. Most ORs were <1.00, some of these
were even significant, mostly for upper respira-
tory symptoms in the non-atopic group. The
few ORs >1.00 were not significant. No
consistent significant association with air pollu-
tion could be detected in the subjects with or
without atopy. Also the prevalences of cough
and phlegm did not show consistent associa-
Table 2 Median individual coeYcients in subgroups of total PEACE study population (coeYcients expressed as l/min change in evening PEF per 100
µg/m3 increase in air pollutant)
Sex Atopy Selection and medication
Lung function
MMEF FEV1
Boy Girl − + Cough− AST− AST+
Lowest
quartile
Above
median
Lowest
quartile
Above
median
PM10:
Lag 0 1.1 −0.5 −0.1 0.8† −0.9 0.7 1.6 −0.1 −0.1 0.6 0.3
Lag 1 −0.5 −0.9 −0.8 −0.4 −1.3‡ −0.3 0.0 −1.4† −0.5 −0.7 −0.9*
Lag 2 −0.5 1.2*‡ 0.4† 0.2 0.0 0.2 2.1 −0.4 0.4 0.6 −0.1
7 Day mean 0.1 1.0 0.5 0.6 −0.9 1.7 1.2 0.1 −0.4 2.6† −0.9‡
Black smoke:
Lag 0 0.7† 0.2 −0.2 1.5† −0.3 0.2 2.6†‡ 0.3 0.6 0.0 1.2†
Lag 1 0.9 −0.3 0.2 0.6 −1.3 0.4 2.4 −0.9 1.8 0.3 0.3
Lag 2 0.2 0.1 −0.2 0.6 −0.9 0.2 2.3† −2.0 0.1 −0.2 0.1
7 Day mean 2.5 2.0 1.8 2.7 −1.2 2.5 10.3*‡ 2.7 1.5 4.3 2.5
SO2:
Lag 0 1.9* 1.4 0.7 2.2† 1.1 1.1 5.3* 0.4 2.1* −0.2 2.1*‡
Lag 1 0.8 0.2 0.3 1.1 −1.1 0.3 4.5*‡ 0.8 0.2 1.9 0.1
Lag 2 0.3 1.5 0.3 1.3 −0.6 1.0 1.3 0.4 1.6† 0.7 1.6
7 Day mean 2.7 0.7 1.4 3.2 −1.3 2.0 12.1* 3.2† 1.4 4.4† 3.0†
NO2:
Lag 0 0.9 0.7 0.3 1.0 0.0 0.9 1.9 0.1 0.8 2.7† 0.6
Lag 1 −0.3 −0.5 −1.1 0.5 −2.0 −0.7 3.3*‡ −1.8 −1.1 −0.3 −0.1
Lag 2 −0.8 1.2 1.2 −0.8 −1.6† 0.9 0.9 1.0 −0.8† 1.7 −0.7†‡
7 Day mean 0.3 1.5 1.0 0.2 −1.7 0.5 5.9 2.6† −1.4†‡ 1.9 −0.3‡
*p<0.05; †p<0.10, sign rank test; ‡p<0.05 Wilcoxon rank sum or Kruskal-Wallis test to test in diVerence in distribution.
Cough−=selected on nightly coughing only, no medication use during study period; AST−=selected on asthma question, no medication use during study period;
AST+=selected on asthma question, and did use medication during study period.
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tions with air pollution in the atopic or
non-atopic subgroup (not presented).
Table 4 shows the results of the stratification
on selection questions and use of medication.
For prevalence of phlegm, the ORs in the
cough− group were mostly >1.00 for PM10, BS,
and NO2, but almost all were non-significant.
The ORs in the other two groups were
predominantly <1.00. For prevalence of lower
respiratory symptoms the ORs were generally
<1.00. Stratification of eVect estimates on
cough and symptoms of the upper respiratory
tract did not show consistent diVerences (not
presented).
The prevalence of use of bronchodilators in
the AST+ group was not related to any compo-
nent of air pollution. For example, the ORs of
PM10 were for lag 0, 0.98 (95% confidence
interval (95% CI) 0.89 to 1.07); lag 1, 0.97
(0.85 to 1.09); lag 2, 0.98 (0.87 to 1.10), and 7
day mean 1.21 (0.71 to 2.07). Restriction of
the data to the centres with the highest mean
prevalence of use of bronchodilators also did
not show significant associations.
Figure 1 shows the ORs of lag 1 of the com-
ponents of air pollution on prevalence of
symptoms after stratification on percentage of
predicted MMEF. The ORs of the children
with a percentage of predicted MMEF above
the median value are all <1.00, with PM10, BS,
and SO2 lag 1 being significant for symptoms of
the upper respiratory tract prevalence and
PM10, BS, and NO2 lag 1 for prevalence of
symptoms of the lower respiratory tract. The
children in the first quartile (low lung function)
had ORs which were predominantly >1.00, BS
lag 1 was significantly associated with cough.
The ORs of lag 0 of PM10, BS, SO2, and NO2 on
symptom prevalence showed the same pattern,
whereas lag 2 and 7 day did not (not
presented).
Finally, stratification by sex of the outcomes
of the analysis of the prevalence of symptoms
did not show clear diVerences between boys
and girls in response to air pollution.
Table 3 Combined OR (95% CI) for 100 µg/m3 increase in air pollution on prevalence of symptoms, in subjects with and without atopy
Upper respiratory symptoms Lower respiratory symptoms Bronchodilator used
Non-atopic Atopic Non-atopic Atopic Non-atopic Atopic
n* OR (95% CI) n* OR (95% CI) n* OR (95% CI) n* OR (95% CI) n* OR (95% CI) n* OR (95% CI)
PM10:
Lag 0 25 0.94 (0.86 to 1.02)‡ 25 0.98 (0.92 to 1.04)† 19 0.91 (0.78 to 1.06)‡ 23 1.05 (0.87 to 1.26)‡ 9 0.95 (0.75 to 1.22)‡ 22 0.96 (0.89 to 1.04)†
Lag 1 25 0.92 (0.87 to 0.97)† 25 0.99 (0.93 to 1.05)† 19 0.96 (0.83 to 1.12)‡ 23 0.99 (0.84 to 1.17)‡ 9 1.09 (0.81 to 1.47)‡ 22 0.92 (0.81 to 1.05)‡
Lag 2 25 0.95 (0.88 to 1.01)‡ 25 0.95 (0.90 to 1.01)† 19 0.90 (0.80 to 1.01)† 23 0.97 (0.85 to 1.11)‡ 9 1.19 (0.89 to 1.59)‡ 22 1.00 (0.84 to 1.20)‡
7 Day mean 25 0.63 (0.45 to 0.86)‡ 25 0.88 (0.68 to 1.15)‡ 19 0.68 (0.33 to 1.41)‡ 23 0.89 (0.50 to 1.59)‡ 9 0.83 (0.48 to 1.43)† 22 1.02 (0.59 to 1.76)‡
Black smoke:
Lag 0 25 1.02 (0.96 to 1.08)† 25 1.00 (0.90 to 1.12)‡ 19 0.86 (0.76 to 0.97)† 23 1.09 (0.88 to 1.36)‡ 9 1.03 (0.86 to 1.22)† 22 0.99 (0.86 to 1.14)†
Lag 1 25 0.93 (0.85 to 1.02)‡ 25 0.92 (0.82 to 1.02)‡ 19 0.90 (0.79 to 1.01)† 23 0.87 (0.69 to 1.10)‡ 9 1.00 (0.64 to 1.58)‡ 22 0.88 (0.74 to 1.06)‡
Lag 2 25 0.92 (0.84 to 1.01)‡ 25 0.91 (0.81 to 1.01)‡ 19 0.93 (0.76 to 1.13)‡ 23 0.93 (0.75 to 1.16)‡ 9 1.03 (0.87 to 1.22)† 22 1.03 (0.86 to 1.22)‡
7 Day mean 25 0.57 (0.39 to 0.82)‡ 25 0.89 (0.59 to 1.32)‡ 19 0.52 (0.20 to 1.34)‡ 23 0.90 (0.36 to 2.23)‡ 9 0.94 (0.35 to 2.52)‡ 22 0.99 (0.44 to 2.20)‡
SO2:
Lag 0 23 0.86 (0.76 to 0.98)‡ 23 0.89 (0.76 to 1.04)‡ 17 0.91 (0.65 to 1.28)‡ 21 0.98 (0.74 to 1.29)‡ 7 0.95 (0.83 to 1.09)† 20 0.94 (0.83 to 1.07)†
Lag 1 23 0.94 (0.88 to 1.01)† 23 0.97 (0.89 to 1.06)† 17 1.08 (0.77 to 1.51)‡ 21 0.98 (0.72 to 1.32)‡ 7 1.00 (0.88 to 1.15)† 20 0.87 (0.69 to 1.08)‡
Lag 2 23 0.96 (0.89 to 1.02)† 23 0.81 (0.70 to 0.94)‡ 17 1.06 (0.80 to 1.41)‡ 21 0.83 (0.62 to 1.10)‡ 7 1.04 (0.91 to 1.18)† 20 1.06 (0.79 to 1.42)‡
7 Day mean 23 0.52 (0.35 to 0.78)‡ 23 0.72 (0.45 to 1.18)‡ 17 0.69 (0.34 to 1.40)‡ 21 1.09 (0.50 to 2.38)‡ 7 0.45 (0.09 to 2.11)‡ 20 0.71 (0.36 to 1.40)‡
NO2:
Lag 0 24 0.96 (0.88 to 1.05)† 24 0.85 (0.77 to 0.94)† 18 1.14 (0.96 to 1.35)† 22 1.13 (0.87 to 1.47)‡ 9 0.94 (0.71 to 1.23)† 22 0.95 (0.82 to 1.09)†
Lag 1 24 0.86 (0.75 to 0.99)‡ 24 1.06 (0.93 to 1.22)‡ 18 0.77 (0.60 to 1.00)‡ 22 0.98 (0.76 to 1.27)‡ 9 1.41 (0.90 to 2.21)‡ 22 0.98 (0.85 to 1.14)†
Lag 2 24 0.98 (0.90 to 1.07)† 24 0.90 (0.79 to 1.03)‡ 18 0.79 (0.60 to 1.02)‡ 22 0.89 (0.66 to 1.21)‡ 9 0.98 (0.58 to 1.63)‡ 22 1.11 (0.88 to 1.42)‡
7 Day mean 24 0.49 (0.28 to 0.85)‡ 24 1.00 (0.60 to 1.69)‡ 18 0.51 (0.18 to 1.48)‡ 22 0.82 (0.28 to 2.39)‡ 9 0.76 (0.34 to 1.69)† 22 1.18 (0.52 to 2.68)‡
*Number of panel specific estimates; †Fixed eVects model; ‡Random eVects model.
Table 4 Combined OR (95% CI) for 100 µg/m3 increase in air pollution on prevalence of cough and phlegm, in subjects selected only on cough and
subjects selected on asthmatic symptoms
Phlegm Lower respiratory symptoms
COUGH- AST+ AST- COUGH- AST+ AST-
n* OR (95% CI) n* OR (95% CI) n* OR (95% CI) n* OR (95% CI) n* OR (95% CI) n* OR (95% CI)
PM10
Lag 0 22 1.02 (0.87 to 1.21)‡ 23 0.98 (0.83 to 1.17)‡ 25 0.95 (0.85 to 1.06)‡ 7 0.96 (0.54 to 1.70)‡ 24 0.87 (0.75 to 1.00)† 22 1.00 (0.84 to 1.18)‡
Lag 1 23 1.09 (0.92 to 1.29)‡ 24 1.04 (0.92 to 1.18)† 25 1.03 (0.94 to 1.13)‡ 7 0.86 (0.59 to 1.26)† 24 0.98 (0.82 to 1.18)‡ 22 1.06 (0.90 to 1.24)‡
Lag 2 23 0.97 (0.79 to 1.19)‡ 23 0.99 (0.84 to 1.16)‡ 25 0.97 (0.87 to 1.08)‡ 7 0.80 (0.54 to 1.18)† 24 0.91 (0.76 to 1.09)‡ 22 1.02 (0.83 to 1.24)‡
7 Day mean 23 1.38 (0.68 to 2.81)‡ 23 1.14 (0.66 to 1.99)‡ 25 0.73 (0.46 to 1.15)‡ 7 0.96 (0.13 to 6.89)‡ 24 0.94 (0.52 to 1.70)‡ 22 0.80 (0.51 to 1.24)‡
Black Smoke
Lag 0 23 1.09 (0.93 to 1.29)‡ 23 0.92 (0.71 to 1.18)‡ 25 0.99 (0.90 to 1.10)† 7 0.79 (0.43 to 1.44)‡ 24 0.96 (0.79 to 1.16)† 22 0.97 (0.77 to 1.23)‡
Lag 1 23 1.07 (0.85 to 1.34)‡ 24 0.99 (0.78 to 1.24)‡ 25 1.12 (0.98 to 1.27)‡ 7 0.80 (0.52 to 1.24)† 24 0.81 (0.63 to 1.04)‡ 22 0.94 (0.74 to 1.21)‡
Lag 2 23 1.02 (0.83 to 1.25)‡ 23 0.94 (0.79 to 1.12)† 25 1.01 (0.91 to 1.11)† 7 0.91 (0.59 to 1.41)† 24 0.97 (0.73 to 1.28)‡ 22 1.00 (0.82 to 1.22)‡
7 Day mean 22 2.02 (0.84 to 4.86)‡ 24 0.76 (0.31 to 1.84)‡ 25 0.52 (0.27 to 1.00)‡ 7 0.95 (0.09 to 9.53)‡ 24 0.94 (0.39 to 2.25)‡ 22 0.61 (0.34 to 1.11)‡
SO2
Lag 0 21 1.05 (0.69 to 1.61)‡ 21 0.92 (0.68 to 1.23)‡ 23 0.87 (0.79 to 0.96)† 7 0.46 (0.23 to 0.93)† 22 0.94 (0.80 to 1.10)† 20 1.12 (0.97 to 1.30)†
Lag 1 21 0.92 (0.74 to 1.14)‡ 21 0.73 (0.44 to 1.22)‡ 23 0.99 (0.85 to 1.15)‡ 7 0.65 (0.19 to 2.22)‡ 22 1.04 (0.75 to 1.44)‡ 20 0.99 (0.87 to 1.14)†
Lag 2 21 0.88 (0.70 to 1.11)‡ 21 0.97 (0.81 to 1.17)† 23 0.94 (0.79 to 1.11)‡ 7 0.96 (0.52 to 1.77)† 22 0.80 (0.58 to 1.10)‡ 20 1.04 (0.92 to 1.19)†
7 Day mean 21 0.89 (0.45 to 1.74)‡ 22 0.58 (0.28 to 1.21)‡ 23 0.60 (0.34 to 1.06)‡ 7 0.31 (0.09 to 1.07)† 22 1.42 (0.57 to 3.57)‡ 20 0.84 (0.46 to 1.55)‡
NO2
Lag 0 21 1.11 (0.77 to 1.60)‡ 23 1.07 (0.76 to 1.49)‡ 23 0.97 (0.87 to 1.08)† 6 0.98 (0.46 to 2.07)‡ 23 1.03 (0.78 to 1.36)‡ 20 1.35 (1.15 to 1.58)†
Lag 1 21 1.00 (0.74 to 1.37)‡ 23 0.92 (0.63 to 1.35)‡ 23 0.96 (0.82 to 1.12)‡ 6 1.09 (0.60 to 2.00)‡ 23 1.01 (0.80 to 1.28)† 20 0.83 (0.58 to 1.17)‡
Lag 2 20 0.85 (0.64 to 1.14)‡ 23 0.99 (0.77 to 1.26)† 23 1.08 (0.92 to 1.26)‡ 6 0.81 (0.51 to 1.28)† 23 0.78 (0.57 to 1.06)‡ 20 0.87 (0.63 to 1.20)‡
7 Day mean 21 4.37 (1.08 to 17.66)‡ 23 0.80 (0.29 to 2.22)‡ 23 0.56 (0.26 to 1.20)‡ 6 1.33 (0.29 to 6.09)† 23 1.47 (0.42 to 5.14)‡ 20 0.28 (0.08 to 1.01)‡
*Number of panel specific estimates; †Fixed eVects model; ‡Random eVects model.
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Discussion
Associations between air pollution and evening
PEF tended to be negative in children selected
on cough only. In asthmatic children who took
respiratory medication, significant positive
associations between air pollution and PEF
were found. Asthmatic children who did not
use medication did not show any association
with air pollution. This pattern was not
confirmed by the respiratory symptoms. In
none of the subgroups was a consistent associ-
ation with respiratory symptoms found. In
children with atopy and children with a low
lung function no air pollution eVects on PEF
and respiratory symptoms were found.
The stratification based on the selection
questionnaire and use of medication showed
that the association of air pollution on evening
PEF in the AST+ group was positive. An expla-
nation might be that the children counteract
the eVects of air pollution on evening PEF by
use of medication during the day. This is
supported by the fact that in the groups not
using respiratory medication the coeYcients
were less positive (AST−) or even negative
(cough−) and that the median coeYcients are
most positive in the centres with the highest
mean daily prevalence of bronchodilator use.
The fact that the prevalence of use of
bronchodilators in the AST+ group was not
related to air pollution weakens this argument.
However, it might be that children increased
the daily dose of bronchodilator use, which is
not reflected in the daily prevalence.
Negative associations between air pollution
and evening PEF mainly occurred in the
cough− group. The regression slope for PM10
lag 1 in the cough− group translates into a
–0.4% change of evening PEF associated with
a 100 µg/m3 change in concentration, only
slightly lower than the combined eVect esti-
mate of –0.7% reported by Dockery and
Pope.18 Children with cough only diVer in cer-
tain characteristics from the children with
asthma. The mean daily prevalence of lower
respiratory symptoms was lower in the cough−
group than in the other groups. An earlier
analysis of the PEACE data showed that
children selected only on cough had a lower
variability in PEF than children selected for
asthmatic symptoms.8 In the Finnish panels
children selected on cough only had a lower
prevalence of atopy and higher percentage of
predicted MMEF19 compared with children
selected on asthmatic symptoms. By contrast
with the outcome in this study, the children
with asthma in the Finnish panels tended to
react more strongly to air pollution than the
children with cough only.5 This was also found
in an earlier panel study in The Netherlands.4
In this study the diVerence in the eVect of air
pollution on morning PEF between the cough−
and the AST+ groups was less pronounced than
the eVect on evening PEF. The morning PEF
measurements were done after getting up and
before taking medication and were preceded by
a long period of exposure to indoor environ-
mental factors. These exposures may have
obscured the relatively weak signal of air pollu-
tion and at the same time the use of medication
did not exert its counteracting eVect in the
AST+ group. The diVerence in response is not
reflected in the eVect estimate of air pollution
on symptom prevalence as the ORs were simi-
lar in the AST+, AST−, and cough− groups.
These results diVer from the results of the
study by Peters et al3 in which the children who
used medication showed larger decrements in
PEF and smaller ORs for prevalence of symp-
toms than children not using medication.
Stratification on sex, atopy, or lung function
did not show consistent diVerences in the
whole population between eVect estimates of
air pollution on PEF or symptom prevalence.
Studies which showed a diVerence in response
between boys and girls focused on chronic
eVects in the general population7 20 whereas the
PEACE study was designed to study acute
eVects in children with symptoms.
One of the possible explanations of the lack
of acute eVects of fluctuations in daily concen-
trations of air pollutants on PEF or prevalence
of symptoms and use of medication in the indi-
vidual panels of PEACE was that subgroups of
children within a panel biased the panel eVect
estimate towards the null or even in the oppo-
Odds ratios (95% CIs) stratified on percentage predicted MMEF. ORs of 100 µg/m3 increase in lag 1 of PM10, black smoke,
SO2, and NO2 on prevalence of (A) cough and phlegm, and (B) upper and lower respiratory symptoms.
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site direction.21 On the basis of the results this
explanation is unlikely for the analysis of
prevalence of symptoms. The relation between
PEF and air pollution diVered between certain
subgroups but still no clear eVects of air pollu-
tion on PEF could be detected. Other possible
explanations for this lack of eVect are discussed
elsewhere.21
This study did not show an eVect of particu-
late air pollution on children’s respiratory
health. This might mean that there really was
no association between particulate air pollution
and children’s respiratory health during the
winter of 1993–4 and that in other studies
which did show associations in panels of
children1 2 4 the composition or level of air pol-
lution was diVerent, or that they had residual
confounding. It might be that the exposure
variables used in this study were not relevant
for respiratory health. One hypothesis is that
not the mass of particles but the number of
ultrafine particles is of importance22 and that
the correlation in time between ultrafine parti-
cle numbers and mass of PM10 is low. A panel
study in Germany showed somewhat stronger
health eVects for particle numbers than for
mass of PM10,
23 but in the Finnish PEACE
panel this was not confirmed.24
In conclusion, none of the predefined poten-
tially more sensitive subgroups showed consist-
ent associations between air pollution, PEF,
and respiratory symptoms. In children with
asthma who used respiratory medication,
significant positive associations between air
pollution and PEF were found. Children with
asthma who did not take medication did not
show any association with air pollution.
The PEACE study was funded within the framework of the
Commission of the European Communities environment
programme, contracts EV5V-CT92-0220, CIPD-CT-92-5052
and ERBCIPD-CT-93-0046. The Finnish, Norwegian and two
Swedish centres were funded by grants from the respective gov-
ernments. The study was coordinated by the Department of
Environmental Sciences, Environmental and Occupational
Health Group, Agricultural University Wageningen, PO Box
238, 6700 AE Wageningen, The Netherlands.
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